| 1 |
Chinoy H, Adimulam S, Marriage F, etal.Interaction of HLADRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study[J].Ann Rheum Dis, 2012, 71(6): 961-965.
|
| 2 |
Svensson J, Holmqvist M, Lundberg IE, et al.Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study [J].Ann Rheum Dis, 2017, 76(11): 1803-1808.
|
| 3 |
Sciorati C, Monno A, Doglio MG, et al.Exacerbation of murine experimental autoimmune myositis by toll-like receptor 7/8 [J].Arthritis Rheumatol, 2018, 70(8): 1276-1287.
|
| 4 |
Rothwell S, Chinoy H, Lamb JA, et al.Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups [J].Ann Rheum Dis, 2019, 78(7): 996-1002.
|
| 5 |
Chinoy H, Lamb JA, Ollier WER, et al.Recent advances in the immunogenetics of idiopathic inflammatory myopathy [J].Arthritis Res Ther, 2011, 13(3): 216.
|
| 6 |
Remuzgo-Martínez S, Atienza-Mateo B, Ocejo-Vinyals JG, et al.Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome [J].Sci Rep, 2021, 11(1): 22574.
|
| 7 |
Sakamoto N, Ishimoto H, Kakugawa T, et al.Elevated a-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease [J].BMC Pulm Med,2018, 18(1): 44.
|
| 8 |
Zhang S, Shu X, Tian X, etal.Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications [J].Clin Exp Immunol, 2014, 177(1): 134-141.
|
| 9 |
Seto N, Torres-Ruiz JJ, Carmona-Rivera C, et al.Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies [J].JCI Insight, 2020, 5(3): e134189.
|
| 10 |
Liu L, Wang J, Zhang P, et al.Promising neutrophil-associated biomarkers in lung diseases of patients with antisynthetase syndrome and dermatomyositis [J].J Immunol Res, 2022, 2022: 1886083.
|
| 11 |
Hervier B, Perez M, Allenbach Y, et al.Involvement of NK cells and NKp30 pathway in antisynthetase syndrome [J].J Immunol, 2016,197(5): 1621-1630.
|
| 12 |
Rossi G, Cavazza A, Spagnolo P, et al.The role of macrophages in interstitial lung diseases: number 3 in the series “pathology for the clinician” edited by peter dorfmuller and alberto cavazza [J].Eur Respir Rev, 2017, 26(145): 170009.
|
| 13 |
González-Pérez MI, Mejía-Hurtado JG, Pérez-Román DI, et al.Evolution of pulmonary function in a cohort of patients with interstitial lung disease and positive for antisynthetase antibodies [J].J Rheumatol, 2020, 47(3): 415-423.
|
| 14 |
Ueshima E, Fujimori M, Kodama H, et al.Macrophage-secreted TGF-beta1 contributes to fibroblast activation and ureteral stricture after ablation injury [J].Am J Physiol Renal Physiol, 2019, 317(7):F52-F64.
|
| 15 |
Kazankov K, Barrera F, Moller HJ, et al.Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C [J].Hepatology,2014, 60 (2): 521-530.
|
| 16 |
Liu Z, Kuang W, Zhou Q, et al.TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway [J].Int J Mol Med, 2018, 42(6):3395-3403.
|
| 17 |
Ramos-Martínez E, Falfán-Valencia R, Pérez-Rubio G, et al.Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163 [J].Immunol Lett, 2022, 248(8): 56-61.
|
| 18 |
Liossis SC, Bounia CA.Treating autoimmune-related interstitial lung disease with B cell depletion [J].Front Med (Lausanne), 2022, 30(9):937561.
|
| 19 |
Soejima M, Kang EH, Gu X, et al.Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis [J].Arthritis Rheum, 2011, 63(2): 479-487.
|
| 20 |
Martin A, Shulman MJ, Tsui FW.Epitope studies indicate that histidyltRNA synthetase is a stimulating antigen in idiopathic myositis [J].FASEB J, 1995, 9(12): 1226-1233.
|
| 21 |
Galindo-Feria AS, Albrecht I, Fernandes-Cerqueira C, et al.Proinflammatory histidyl-transfer RNA synthetase-specific CD4+T cells in the blood and lungs of patients with idiopathic inflammatory myopathies [J].Arthritis Rheumatol, 2020, 72(1): 179-191.
|
| 22 |
Krystufková O, Vallerskog T, Helmers SB, et al.Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies [J].Ann Rheum Dis, 2009, 68(6):836-843.
|
| 23 |
Howard OM, Dong HF, Yang D, et al.Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells[J].J Exp Med, 2002, 196(6): 781-791.
|
| 24 |
Ramos-Martinez E, Falfán-Valencia R, Pérez-Rubio G, et al.Antiaminoacyl transfer-RNA-synthetases (Anti-tRNA) autoantibodies associated with interstitial lung disease: pulmonary disease progression has a persistent elevation of the Th17 cytokine profile [J].J Clin Med,2020, 9(5): 1356.
|
| 25 |
Behrens Pinto GL, Carboni RCS, de Souza FHC, et al.A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome [J].Clin Rheumatol, 2020, 39(9): 2763-2771.
|
| 26 |
Rajendran V, Kalita P, Shukla H, et al.Aminoacyl-tRNA synthetases:Structure, function, and drug discovery [J].Int J Biol Macromol, 2018,111(5): 400-414.
|
| 27 |
Jiang L, Jones J, Yang XL.Human diseases linked to cytoplasmic aminoacyl-tRNA synthetases [J].Enzymes, 2020, 48: 277-319.
|
| 28 |
Soejima M, Kang EH, Gu X, et al.Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis [J].Arthritis Rheum, 2011, 63(2): 479-487.
|
| 29 |
Jung HJ, Park SH, Cho KM, et al.Threonyl-tRNA synthetase promotes T helper type 1 cell responses by inducing dendritic cell maturation and IL-12 production via an NF-kappaB pathway [J].Front Immunol,2020, 11: 571959.
|
| 30 |
Dai C, Reyes-Ordonez A, You JS, et al.A non-translational role of threonyl-tRNA synthetase in regulating JNK signaling during myogenic differentiation [J].FASEB J, 2021, 35(10): e21948.
|
| 31 |
Zhang H, Yang XL, Sun L.The uniqueness of AlaRS and its human disease connections [J].RNA Biol, 2021, 18(11): 1501-1511.
|
| 32 |
郑婵新, 钟春玖.甘氨酰-tRNA 合成酶相关的遗传性周围神经病研究进展 [J/OL].中华临床医师杂志(电子版), 2009, 3(1): 104-107.
|
| 33 |
Adams RA, Fernandes-Cerqueira C, Notarnicola A, et al.Serumcirculating his-tRNA synthetase inhibits organ-targeted immune responses [J].Cell Mol Immunol, 2021, 18(6): 1463-1475.
|
| 34 |
Kwon NH, Fox PL, Kim S.Aminoacyl-tRNA synthetases as therapeutic targets [J].Nat Rev Drug Discov, 2019, 18(8): 629-650.
|
| 35 |
Park JS, Park MC, Lee KY, etal.Unique N-terminal extension domain of human asparaginyl-tRNA synthetase elicits CCR3-mediated chemokine activity [J].Int J Biol Macromol, 2018, 120(PtA): 835-845.
|
| 36 |
Cavagna L, Trallero-Araguás E, Meloni F, et al.Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course [J].J Clin Med, 2019, 8(11): 2013.
|
| 37 |
Jiang M, Dong X, Zheng Y.Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies [J].Medicine(Baltimore), 2021, 100(19): e25816.
|
| 38 |
Abel A, Lazaro E, Ralazamahaleo M, et al.Phenotypic profiles among 72 caucasian and afro-caribbean patients with antisynthetase syndrome involving anti-PL7 or anti-PL12 autoantibodies [J].Eur J Intern Med,2023, 115: 104-113.
|
| 39 |
Zhan X, Yan W, Wang Y, et al.Clinical features of anti-synthetase syndrome associated interstitial lung disease: A retrospective cohort in China [J].BMC Pulm Med, 2021, 21(1): 57.
|
| 40 |
Hervier B, Wallaert B, Hachulla E, et al.Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase(Anti-PL12) antibodies: A retrospective study of 17 cases [J].Rheumatology, 2010, 49(5): 972-976.
|
| 41 |
Abel A, Lazaro E, Ralazamahaleo M, et al.Phenotypic profiles among 72 caucasian and afro-caribbean patients with antisynthetase syndrome involving anti-PL7 or anti-PL12 autoantibodies [J].Eur J Intern Med,2023, 115: 104-113.
|
| 42 |
Zhang Y, Ge Y, Yang H, et al.Clinical features and outcomes of the patients with anti-Glycyl tRNA synthetase syndrome [J].Clin Rheumatol, 2020, 39(8): 2417-2424.
|
| 43 |
朱玉静, 王磊, 吕成银, 等.抗EJ 抗体阳性抗合成酶综合征相关间质性肺疾病复发的临床特征分析 [J].北京大学学报(医学版),2024, 56(6): 980-986.
|
| 44 |
周云, 吕成银, 尤含笑, 等.不同抗体亚型抗合成酶综合征并发间质性肺疾病临床特征分析 [J].中华风湿病学杂志, 2024, 28(8):538-544.
|
| 45 |
Ge YP, Zhang YL, Shu XM, et al.Clinical characteristics of antiisoleucyl-tRNA synthetase antibody associated syndrome and comparison with different patient cohorts [J].Clin Exp Rheumatol,2022, 40(3): 625-630.
|
| 46 |
Vulsteke JB, Satoh M, Malyavantham K, et al.Anti-OJ autoantibodies:Rare or Underdetected? [J].Autoimmun Rev, 2019, 18(7): 658-664.
|
| 47 |
Moll SA, Platenburg M, Platteel ACM, et al.Prevalence of novel myositis autoantibodies in a large cohort of patients with interstitial lung disease [J].J Clin Med, 2020, 9(9): 2944.
|
| 48 |
Wu S, Xiao X, Zhang Y, et al.Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification[J].Ann Rheum Dis, 2024, 83(6): 775-786.
|